Original Article
Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis
Ran Hu, Zhiting Zhao, Yue Shi, Meiqi Shi, Guohao Xia, Shaorong Yu, Jifeng Feng